$IBIO Recent News Fight against Ebola spreads
Post# of 74540
Posted On: 10/13/2014 1:15:56 PM
$IBIO Recent News
Fight against Ebola spreads to other nations 59 min ago - Russ Britt
Ebola stocks: 2 to sell, and 5 to consider buying 12:09 p.m. Today - The Trading Deck
Stocks teeter on a key trend line as earnings pile up 8:19 a.m. Today - Shawn Langlois
Ebola-related shares rally in premarket as Texas nurse tests positive 7:47 a.m. Today - Ciara Linnane
Drug indexes split; Xoma in spotlight 12:01 p.m. Jan. 4, 2011 - Val Brickates Kennedy
Ebola traders need to rest 10:52 a.m. Today - Seeking Alpha
Why iBio (IBIO) Stock Hit a One-Year High Today 10:39 a.m. Today - TheStreet.com
iBio Is Not The Partner Of Mapp's Ebola Drug 9:17 a.m. Today - Seeking Alpha
IBio Is Not The Partner Of ZMAPP's Ebola Drug 9:17 a.m. Today - Seeking Alpha
Ebola Stocks: A Real Portfolio Killer 7:35 a.m. Today - Seeking Alpha
Ibio jumps on possible ZMapp production ramp 4:18 p.m. Oct. 10, 2014 - Seeking Alpha
10-K: IBIO, INC. 5:20 p.m. Sept. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
iBio set to receive two European patents 11:20 a.m. Aug. 28, 2014 - Seeking Alpha
iBio closes stock purchase agreement 11:21 a.m. Aug. 26, 2014 - Seeking Alpha
10-Q: IBIO, INC. 11:18 a.m. May 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: IBIO, INC. 8:36 a.m. Feb. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: IBIO, INC. 6:22 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Sell iBio As Dilution Risk Is Running High And Insiders Are Selling Aggressively 11:45 a.m. Oct. 11, 2013 - Seeking Alpha
2 Penny Stocks to Try 7:21 a.m. June 12, 2013 - InvestorPlace.com
2 Penny Stocks to Try 7:21 a.m. June 12, 2013 - InvestorPlace.com
10-Q: IBIO, INC. 1:44 p.m. May 20, 2013 - Edgar Online - (EDG = 10Q, 10K)
GE Healthcare: Driving Growth Through Alliances And Acquisitions 7:09 a.m. April 12, 2013 - Seeking Alpha
Flu Stocks For Investors To Consider 10:00 a.m. April 8, 2013 - Seeking Alpha
Change In Global Weather Patterns, Australia Heat Wave, Flu Virus 4:37 p.m. Jan. 14, 2013 - Seeking Alpha
Speculative Flu Vaccine Stocks To Consider: Novavax, iBio, BioCryst, And Inovio 3:33 p.m. Jan. 11, 2013 - Seeking Alpha
iBio Reports on Filing of 2014 Annual Report 5:00 p.m. Oct. 3, 2014 - Marketwire
Dr. Thomas A. Medsger Jr. Joins iBio Clinical Advisory Board 8:32 a.m. Sept. 2, 2014 - Marketwire
iBio Receives European Patent Allowances for Protein Expression Technology 8:31 a.m. Aug. 28, 2014 - Marketwire
iBio Enters Into $10 Million Common Stock Purchase Agreement With Aspire Capital 8:31 a.m. Aug. 26, 2014 - Marketwire
iBio Forms Marketing Collaboration With Kanematsu Chemicals Corporation to Target Japanese Market 8:32 a.m. Aug. 14, 2014 - Marketwire
iBio Appoints Another IPF Expert, Dr. J. Terrill Huggins, to Clinical Advisory Board 8:31 a.m. July 30, 2014 - Marketwire
iBio Appoints Dr. Richard M. Silver to Clinical Advisory Board 8:32 a.m. July 21, 2014 - Marketwire
iBio Appoints Dr. Timothy Blackwell to New Clinical Advisory Board 8:32 a.m. July 16, 2014 - Marketwire
iBio Expands Commercial Collaboration With Bio-Manguinhos and Fraunhofer 2:24 a.m. June 18, 2014 - Marketwire
iBio Expands IP Protection of Biotherapeutic Product for Treatment of Fibrosis 8:31 a.m. June 10, 2014 - Marketwire
iBio European Patent on iBioModulator Technology Emerges From Opposition Period 8:31 a.m. June 5, 2014 - Marketwire
iBio Receives Patent Allowance in China for Fusion Protein Compositions and Technology 8:32 a.m. April 24, 2014 - Marketwire
iBio Receives Patent Allowances for Pandemic Influenza Therapeutics 8:32 a.m. March 27, 2014 - Marketwire
iBio to Present at the 26th Annual ROTH Conference on March 10, 2014 9:32 a.m. March 4, 2014 - Marketwire
Global Biosimilars Market 2014-2018 11:28 a.m. Feb. 27, 2014 - PR Newswire - PRF
Phase 1 Clinical Trial Begins for Malaria Vaccine Candidate Based on iBio's Proprietary Technology 9:32 a.m. Feb. 10, 2014 - Marketwire
iBio Adds Biotherapeutic Product for Treatment of Fibrosis to Its Proprietary Product Pipeline 9:31 a.m. Jan. 30, 2014 - Marketwire
iBio and Caliber Designate New Fusion Protein as Target Product Under License and Collaboration Agreement 9:31 a.m. Jan. 15, 2014 - Marketwire
Relmada Therapeutics Inc. Appoints Douglas J. Beck As Chief Financial Officer 8:00 a.m. Dec. 11, 2013 - PR Newswire
iBio Appoints Senior Management for New Business Unit, iBio Brazil 4:00 p.m. Nov. 5, 2013 - Marketwire
Fight against Ebola spreads to other nations 59 min ago - Russ Britt
Ebola stocks: 2 to sell, and 5 to consider buying 12:09 p.m. Today - The Trading Deck
Stocks teeter on a key trend line as earnings pile up 8:19 a.m. Today - Shawn Langlois
Ebola-related shares rally in premarket as Texas nurse tests positive 7:47 a.m. Today - Ciara Linnane
Drug indexes split; Xoma in spotlight 12:01 p.m. Jan. 4, 2011 - Val Brickates Kennedy
Ebola traders need to rest 10:52 a.m. Today - Seeking Alpha
Why iBio (IBIO) Stock Hit a One-Year High Today 10:39 a.m. Today - TheStreet.com
iBio Is Not The Partner Of Mapp's Ebola Drug 9:17 a.m. Today - Seeking Alpha
IBio Is Not The Partner Of ZMAPP's Ebola Drug 9:17 a.m. Today - Seeking Alpha
Ebola Stocks: A Real Portfolio Killer 7:35 a.m. Today - Seeking Alpha
Ibio jumps on possible ZMapp production ramp 4:18 p.m. Oct. 10, 2014 - Seeking Alpha
10-K: IBIO, INC. 5:20 p.m. Sept. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
iBio set to receive two European patents 11:20 a.m. Aug. 28, 2014 - Seeking Alpha
iBio closes stock purchase agreement 11:21 a.m. Aug. 26, 2014 - Seeking Alpha
10-Q: IBIO, INC. 11:18 a.m. May 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: IBIO, INC. 8:36 a.m. Feb. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: IBIO, INC. 6:22 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Sell iBio As Dilution Risk Is Running High And Insiders Are Selling Aggressively 11:45 a.m. Oct. 11, 2013 - Seeking Alpha
2 Penny Stocks to Try 7:21 a.m. June 12, 2013 - InvestorPlace.com
2 Penny Stocks to Try 7:21 a.m. June 12, 2013 - InvestorPlace.com
10-Q: IBIO, INC. 1:44 p.m. May 20, 2013 - Edgar Online - (EDG = 10Q, 10K)
GE Healthcare: Driving Growth Through Alliances And Acquisitions 7:09 a.m. April 12, 2013 - Seeking Alpha
Flu Stocks For Investors To Consider 10:00 a.m. April 8, 2013 - Seeking Alpha
Change In Global Weather Patterns, Australia Heat Wave, Flu Virus 4:37 p.m. Jan. 14, 2013 - Seeking Alpha
Speculative Flu Vaccine Stocks To Consider: Novavax, iBio, BioCryst, And Inovio 3:33 p.m. Jan. 11, 2013 - Seeking Alpha
iBio Reports on Filing of 2014 Annual Report 5:00 p.m. Oct. 3, 2014 - Marketwire
Dr. Thomas A. Medsger Jr. Joins iBio Clinical Advisory Board 8:32 a.m. Sept. 2, 2014 - Marketwire
iBio Receives European Patent Allowances for Protein Expression Technology 8:31 a.m. Aug. 28, 2014 - Marketwire
iBio Enters Into $10 Million Common Stock Purchase Agreement With Aspire Capital 8:31 a.m. Aug. 26, 2014 - Marketwire
iBio Forms Marketing Collaboration With Kanematsu Chemicals Corporation to Target Japanese Market 8:32 a.m. Aug. 14, 2014 - Marketwire
iBio Appoints Another IPF Expert, Dr. J. Terrill Huggins, to Clinical Advisory Board 8:31 a.m. July 30, 2014 - Marketwire
iBio Appoints Dr. Richard M. Silver to Clinical Advisory Board 8:32 a.m. July 21, 2014 - Marketwire
iBio Appoints Dr. Timothy Blackwell to New Clinical Advisory Board 8:32 a.m. July 16, 2014 - Marketwire
iBio Expands Commercial Collaboration With Bio-Manguinhos and Fraunhofer 2:24 a.m. June 18, 2014 - Marketwire
iBio Expands IP Protection of Biotherapeutic Product for Treatment of Fibrosis 8:31 a.m. June 10, 2014 - Marketwire
iBio European Patent on iBioModulator Technology Emerges From Opposition Period 8:31 a.m. June 5, 2014 - Marketwire
iBio Receives Patent Allowance in China for Fusion Protein Compositions and Technology 8:32 a.m. April 24, 2014 - Marketwire
iBio Receives Patent Allowances for Pandemic Influenza Therapeutics 8:32 a.m. March 27, 2014 - Marketwire
iBio to Present at the 26th Annual ROTH Conference on March 10, 2014 9:32 a.m. March 4, 2014 - Marketwire
Global Biosimilars Market 2014-2018 11:28 a.m. Feb. 27, 2014 - PR Newswire - PRF
Phase 1 Clinical Trial Begins for Malaria Vaccine Candidate Based on iBio's Proprietary Technology 9:32 a.m. Feb. 10, 2014 - Marketwire
iBio Adds Biotherapeutic Product for Treatment of Fibrosis to Its Proprietary Product Pipeline 9:31 a.m. Jan. 30, 2014 - Marketwire
iBio and Caliber Designate New Fusion Protein as Target Product Under License and Collaboration Agreement 9:31 a.m. Jan. 15, 2014 - Marketwire
Relmada Therapeutics Inc. Appoints Douglas J. Beck As Chief Financial Officer 8:00 a.m. Dec. 11, 2013 - PR Newswire
iBio Appoints Senior Management for New Business Unit, iBio Brazil 4:00 p.m. Nov. 5, 2013 - Marketwire
(0)
(0)Scroll down for more posts ▼